World's Best Scientists 2026 revealed!
Bryan T. Hennessy

Bryan T. Hennessy

D-Index & Metrics

Medicine

D-Index
77
Citations
37558
World Ranking
18247
National Ranking
50

Bryan T. Hennessy publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bryan T. Hennessy sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 353 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Bryan T. Hennessy D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bryan T. Hennessy sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Bryan T. Hennessy is affiliated with Beaumont Hospital in Ireland. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology. The work extensively covers subfields such as Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, and Pathology and Forensic Medicine.

The scientist's publications reflect significant contributions to cancer research and treatment, as well as respiratory and molecular biology studies. Key topics in their research include:

  • HER2/EGFR in Cancer Research
  • Cancer Treatment and Pharmacology
  • Cancer Genomics and Diagnostics
  • Advanced Breast Cancer Therapies
  • Breast Cancer Treatment Studies
  • Lung Cancer Treatments and Mutations
  • Chronic Lymphocytic Leukemia Research

Frequent publication venues for Bryan T. Hennessy's work are:

  • Journal of Clinical Oncology
  • Irish Journal of Medical Science (1971 -)
  • Cancer Research
  • Annals of Oncology
  • Neurology

Their recent notable papers include:

  • "Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer" (2023), Journal of Clinical Oncology
  • "Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study" (2021), JAMA Neurology
  • "Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19)" (2020), Thorax
  • "Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer" (2020), Clinical Cancer Research
  • "BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis" (2020), JNCI Journal of the National Cancer Institute

Hennessy's collaborative work includes frequent co-authors such as:

  • Patrick G. Morris
  • Sinéad Toomey
  • Oscar S. Breathnach
  • Liam Grogan
  • John Crown

Best Publications

  • Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

    Cornelia Liedtke;Chafika Mazouni;Kenneth R. Hess;Fabrice André

  • Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery

    Bryan T. Hennessy;Debra L. Smith;Prahlad T. Ram;Yiling Lu

  • A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

    Katrien Berns;Hugo M. Horlings;Bryan T. Hennessy;Mandy Madiredjo

  • The biology of ovarian cancer: new opportunities for translation

    Robert C. Bast;Bryan Hennessy;Gordon B. Mills

  • Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy

    W. Fraser Symmans;Florentia Peintinger;Christos Hatzis;Radhika Rajan

  • An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.

    Katherine Stemke-Hale;Ana Maria Gonzalez-Angulo;Ana Lluch;Richard M. Neve

  • Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.

    Bryan T. Hennessy;Ana Maria Gonzalez-Angulo;Katherine Stemke-Hale;Michael Z. Gilcrease

  • The Energy Sensing LKB1-AMPK Pathway Regulates p27kip1 Phosphorylation Mediating the Decision to Enter Autophagy or Apoptosis

    Jiyong Liang;Shan H. Shao;Shan H. Shao;Zhi Xiang Xu;Bryan Hennessy

  • Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.

    Melinda L. Telli;Kirsten M. Timms;Julia Reid;Bryan Hennessy

  • Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells

    Raoul Tibes;Yi Hua Qiu;Yiling Lu;Bryan Hennessy

  • Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer

    Victor Abkevich;Kirsten Timms;Bryan T. Hennessy;Jennifer Potter

  • Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer

    Ana M. Gonzalez-Angulo;Kirsten M. Timms;Shuying Liu;Huiqin Chen

  • Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer

    Todd W. Miller;Bryan T. Hennessy;Ana M. González-Angulo;Emily M. Fox

  • Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy.

    Seth A. Wander;Bryan T. Hennessy;Joyce M. Slingerland

  • Subtype and pathway specific responses to anticancer compounds in breast cancer.

    Laura M. Heiser;Anguraj Sadanandam;Wen-Lin Kuo;Stephen C. Benz

  • Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis

    Colin Clarke;Stephen F. Madden;Padraig Doolan;Sinead T. Aherne

  • Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.

    Suzanne A. Eccles;Eric O. Aboagye;Simak Ali;Annie S. Anderson

  • High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability

    Lydia W.T. Cheung;Bryan T. Hennessy;Bryan T. Hennessy;Jie Li;Shuangxing Yu

  • Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy

    Bryan T. Hennessy;Gabriel N. Hortobagyi;Roman Rouzier;Henry Kuerer

  • Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer

    Bryan T.J. Hennessy;Kirsten M. Timms;Mark S. Carey;Alexander Gutin

Frequent Co-Authors

Gordon B. Mills
Gordon B. Mills Oregon Health & Science University
Ana M. Gonzalez-Angulo
Ana M. Gonzalez-Angulo The University of Texas MD Anderson Cancer Center
John Crown
John Crown Dublin City University
Yiling Lu
Yiling Lu The University of Texas MD Anderson Cancer Center
Jochen H. M. Prehn
Jochen H. M. Prehn Royal College of Surgeons in Ireland
Gabriel N. Hortobagyi
Gabriel N. Hortobagyi The University of Texas MD Anderson Cancer Center
Vicente Valero
Vicente Valero The University of Texas MD Anderson Cancer Center
Kenneth J. O'Byrne
Kenneth J. O'Byrne Queensland University of Technology
Karen H. Lu
Karen H. Lu The University of Texas MD Anderson Cancer Center
Ana Lluch
Ana Lluch University of Valencia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring medical professionals have a wide range of online degree options and career pathways that extend beyond traditional MD programs. For nurses looking to advance their education, the best online bsn to dnp programs offer a flexible route to acquire leadership and clinical expertise at the doctoral level.

Those interested in pharmaceuticals can consider the best online pharmacy school programs, which prepare graduates for dynamic roles in the healthcare industry, from research to patient care.

The demand for tech-savvy professionals is growing, especially in data management. Earning a health information management degree online can open doors to vital positions in maintaining healthcare data security and integrity.

For those seeking a fast track into healthcare administration, online medical billing and coding courses offer practical skills needed to enter this in-demand field. Online programs provide flexibility for students balancing work or family, allowing for career advancement or a shift into new medical roles from anywhere in the world.

Best Scientists Citing Bryan T. Hennessy

Trending Scientists

Recently Published Articles